Charles Schwab’s LifePoint Health, Inc. LPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-261,627
| Closed | -$16.8M | – | 3197 |
|
|
2018
Q3 | $16.8M | Buy |
261,627
+12,518
| +5% | +$763K | 0.01% | 1261 |
|
|
2018
Q2 | $12.2M | Buy |
249,109
+77,205
| +45% | +$4M | 0.01% | 1454 |
|
|
2018
Q1 | $8.08M | Buy |
171,904
+2,361
| +1% | +$114K | 0.01% | 1648 |
|
|
2017
Q4 | $8.44M | Buy |
169,543
+20,781
| +14% | +$1.03M | 0.01% | 1604 |
|
|
2017
Q3 | $8.61M | Buy |
148,762
+10,757
| +8% | +$640K | 0.01% | 1529 |
|
|
2017
Q2 | $9.27M | Buy |
138,005
+5,177
| +4% | +$327K | 0.01% | 1407 |
|
|
2017
Q1 | $8.7M | Buy |
132,828
+10,323
| +8% | +$638K | 0.01% | 1407 |
|
|
2016
Q4 | $6.96M | Buy |
122,505
+9,820
| +9% | +$568K | 0.01% | 1520 |
|
|
2016
Q3 | $6.67M | Sell |
112,685
-5,919
| -5% | -$355K | 0.01% | 1450 |
|
|
2016
Q2 | $7.75M | Sell |
118,604
-105,544
| -47% | -$7.17M | 0.01% | 1250 |
|
|
2016
Q1 | $15.5M | Sell |
224,148
-14,709
| -6% | -$982K | 0.02% | 766 |
|
|
2015
Q4 | $17.5M | Buy |
238,857
+812
| +0.3% | +$57.8K | 0.02% | 656 |
|
|
2015
Q3 | $16.9M | Buy |
238,045
+2,149
| +0.9% | +$174K | 0.02% | 635 |
|
|
2015
Q2 | $20.5M | Buy |
235,896
+54,068
| +30% | +$4.09M | 0.03% | 559 |
|
|
2015
Q1 | $13.4M | Buy |
181,828
+25,349
| +16% | +$1.8M | 0.02% | 794 |
|
|
2014
Q4 | $11.3M | Buy |
156,479
+8,064
| +5% | +$559K | 0.02% | 809 |
|
|
2014
Q3 | $10.3M | Buy |
148,415
+4,776
| +3% | +$336K | 0.02% | 806 |
|
|
2014
Q2 | $8.92M | Sell |
143,639
-79,261
| -36% | -$4.65M | 0.02% | 929 |
|
|
2014
Q1 | $12.2M | Sell |
222,900
-14,442
| -6% | -$772K | 0.02% | 668 |
|
|
2013
Q4 | $12.5M | Buy |
237,342
+24,718
| +12% | +$1.24M | 0.02% | 589 |
|
|
2013
Q3 | $10.1M | Buy |
212,624
+50,755
| +31% | +$2.43M | 0.02% | 637 |
|
|
2013
Q2 | $7.87M | Buy |
+161,869
| New | +$7.76M | 0.02% | 698 |
|
Other funds holding LPNT
Charles Schwab's LPNT Position: Q4 2018 in Review
Charles Schwab sold out of LifePoint Health, Inc. (LPNT) in Q4 2018, closing a stake of 261,627 shares — an estimated $16.8M sold.
Charles Schwab first reported a position in LPNT in Q2 2013 and held it in 22 quarters. The position peaked at $20.5M in Q2 2015. 3 funds tracked by Wall St. Rank hold LPNT as of Q4 2018.
- Charles Schwab reported no remaining LifePoint Health, Inc. position as of Q4 2018 after selling out during the quarter.
- Charles Schwab sold 261,627 LifePoint Health, Inc. shares in Q4 2018, an estimated $16.8M.
- Charles Schwab first reported a position in LifePoint Health, Inc. in Q2 2013 and held it in 22 quarters.
- Charles Schwab's LifePoint Health, Inc. position peaked at $20.5M in Q2 2015.
- 3 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2018.
Based on Charles Schwab's 13F filing for Q4 2018, filed 14 Feb 2019.